These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2590607)

  • 1. Structural requirements for bioactivation of anticonvulsants to cytotoxic metabolites in vitro.
    Riley RJ; Kitteringham NR; Park BK
    Br J Clin Pharmacol; 1989 Oct; 28(4):482-7. PubMed ID: 2590607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of enzyme induction on the cytochrome P450-mediated bioactivation of carbamazepine by mouse liver microsomes.
    Pirmohamed M; Kitteringham NR; Breckenridge AM; Park BK
    Biochem Pharmacol; 1992 Dec; 44(12):2307-14. PubMed ID: 1472096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An in vitro study of the microsomal metabolism and cellular toxicity of phenytoin, sorbinil and mianserin.
    Riley RJ; Maggs JL; Lambert C; Kitteringham NR; Park BK
    Br J Clin Pharmacol; 1988 Nov; 26(5):577-88. PubMed ID: 3207562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formation of cytotoxic metabolites from phenytoin, imipramine, desipramine, amitriptyline and mianserin by mouse and human hepatic microsomes.
    Riley RJ; Roberts P; Kitteringham NR; Park BK
    Biochem Pharmacol; 1990 Jun; 39(12):1951-8. PubMed ID: 2353936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peroxidase-mediated bioactivation of hydroxylated metabolites of carbamazepine and phenytoin.
    Lu W; Uetrecht JP
    Drug Metab Dispos; 2008 Aug; 36(8):1624-36. PubMed ID: 18463199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein-reactive metabolites of carbamazepine in mouse liver microsomes.
    Lillibridge JH; Amore BM; Slattery JT; Kalhorn TF; Nelson SD; Finnell RH; Bennett GD
    Drug Metab Dispos; 1996 May; 24(5):509-14. PubMed ID: 8723729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on interactions between traditional herbal and Western medicines. IV: lack of pharmacokinetic interactions between Saiko-ka-ryukotsu-borei-to and carbamazepine in rats.
    Ohnishi N; Nakasako S; Okada K; Umehara S; Takara K; Nagasawa K; Yoshioka M; Kuroda K; Yokoyama T
    Eur J Drug Metab Pharmacokinet; 2001; 26(1-2):129-35. PubMed ID: 11554427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of primary and sequential bioactivation pathways of carbamazepine in human liver microsomes using liquid chromatography/tandem mass spectrometry.
    Bu HZ; Zhao P; Dalvie DK; Pool WF
    Rapid Commun Mass Spectrom; 2007; 21(20):3317-22. PubMed ID: 17879390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. P450 2C18 catalyzes the metabolic bioactivation of phenytoin.
    Kinobe RT; Parkinson OT; Mitchell DJ; Gillam EM
    Chem Res Toxicol; 2005 Dec; 18(12):1868-75. PubMed ID: 16359177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An investigation of the formation of cytotoxic, protein-reactive and stable metabolites from carbamazepine in vitro.
    Pirmohamed M; Kitteringham NR; Guenthner TM; Breckenridge AM; Park BK
    Biochem Pharmacol; 1992 Apr; 43(8):1675-82. PubMed ID: 1575766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective liver enzyme induction by carbamazepine and phenytoin in Chinese epileptics.
    Tomlinson B; Young RP; Ng MC; Anderson PJ; Kay R; Critchley JA
    Eur J Clin Pharmacol; 1996; 50(5):411-5. PubMed ID: 8839665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formation of active metabolites of anticonvulsant drugs. A review of their pharmacokinetic and therapeutic significance.
    Eadie MJ
    Clin Pharmacokinet; 1991 Jul; 21(1):27-41. PubMed ID: 1914340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticonvulsant toxicity in vitro: possible role of arene oxides.
    Spielberg SP; Gordon GB; Blake DA; Mellits ED; Bross DS
    J Pharmacol Exp Ther; 1981 May; 217(2):386-9. PubMed ID: 7229980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo and in vitro correlation of microsomal epoxide hydrolase inhibition by progabide.
    Kroetz DL; Loiseau P; Guyot M; Levy RH
    Clin Pharmacol Ther; 1993 Nov; 54(5):485-97. PubMed ID: 8222491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinically significant pharmacokinetic drug interactions with carbamazepine. An update.
    Spina E; Pisani F; Perucca E
    Clin Pharmacokinet; 1996 Sep; 31(3):198-214. PubMed ID: 8877250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carbamazepine pharmacokinetics are not affected by zonisamide: in vitro mechanistic study and in vivo clinical study in epileptic patients.
    Ragueneau-Majlessi I; Levy RH; Bergen D; Garnett W; Rosenfeld W; Mather G; Shah J; Grundy JS
    Epilepsy Res; 2004 Nov; 62(1):1-11. PubMed ID: 15519127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carbamazepine-hypersensitivity: assessment of clinical and in vitro chemical cross-reactivity with phenytoin and oxcarbazepine.
    Pirmohamed M; Graham A; Roberts P; Smith D; Chadwick D; Breckenridge AM; Park BK
    Br J Clin Pharmacol; 1991 Dec; 32(6):741-9. PubMed ID: 1768568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nafimidone, an imidazole anticonvulsant, and its metabolite as potent inhibitors of microsomal metabolism of phenytoin and carbamazepine.
    Kapetanovic IM; Kupferberg HJ
    Drug Metab Dispos; 1984; 12(5):560-4. PubMed ID: 6149905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioactivation of dapsone to a cytotoxic metabolite by human hepatic microsomal enzymes.
    Coleman MD; Breckenridge AM; Park BK
    Br J Clin Pharmacol; 1989 Oct; 28(4):389-95. PubMed ID: 2590600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of human liver microsomal epoxide hydrolase by valproate and valpromide: in vitro/in vivo correlation.
    Kerr BM; Rettie AE; Eddy AC; Loiseau P; Guyot M; Wilensky AJ; Levy RH
    Clin Pharmacol Ther; 1989 Jul; 46(1):82-93. PubMed ID: 2501059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.